M
Manuel D. Cerqueira
Researcher at Cleveland Clinic Lerner College of Medicine
Publications - 62
Citations - 11467
Manuel D. Cerqueira is an academic researcher from Cleveland Clinic Lerner College of Medicine. The author has contributed to research in topics: Myocardial perfusion imaging & Appropriate Use Criteria. The author has an hindex of 28, co-authored 62 publications receiving 11172 citations. Previous affiliations of Manuel D. Cerqueira include Cleveland Clinic & American Heart Association.
Papers
More filters
Journal ArticleDOI
Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart
Manuel D. Cerqueira,Neil J. Weissman,Vasken Dilsizian,Alice K. Jacobs,Sanjiv Kaul,Warren K. Laskey,Dudley J. Pennell,John A. Rumberger,Thomas J. Ryan,Mario S. Verani +9 more
TL;DR: A remarkable committee was convened: The American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging came to an agreement upon all aspects of nomenclature and anatomic descriptions of the heart.
Journal ArticleDOI
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging)
Francis J. Klocke,Michael G. Baird,Beverly H. Lorell,Timothy M. Bateman,Joseph V. Messer,Daniel S. Berman,Patrick T. O'Gara,Blase A. Carabello,Richard O. Russell,Manuel D. Cerqueira,Martin St. John Sutton,Anthony N. DeMaria,James E. Udelson,J. Ward Kennedy,Mario S. Verani,Kim A. Williams,Elliott M. Antman,Sidney C. Smith,Joseph S. Alpert,Gabriel Gregoratos,Jeffrey L. Anderson,Loren F. Hiratzka,David P. Faxon,Sharon A. Hunt,Valentin Fuster,Alice K. Jacobs,Raymond J. Gibbons +26 more
TL;DR: The American College of Cardiology/AHA Task Force on Practice Guidelines regularly reviews existing guidelines to determine when an update or full revision is needed.
Journal ArticleDOI
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography
Allen J. Taylor,Manuel D. Cerqueira,John McB. Hodgson,Daniel B. Mark,James K. Min,Patrick T. O'Gara,Geoffrey D. Rubin,Christopher M. Kramer,Daniel S. Berman,Alan S. Brown,Farooq A. Chaudhry,Ricardo C. Cury,Milind Y. Desai,Andrew J. Einstein,Antoinette S. Gomes,Robert A. Harrington,Udo Hoffmann,Rahul Khare,John R. Lesser,Christopher J. McGann,Alan Rosenberg,Robert S. Schwartz,Marc E. Shelton,Gerald W. Smetana,Sidney C. Smith,Michael J. Wolk,Joseph M. Allen,Steven R. Bailey,Pamela S. Douglas,Robert C. Hendel,Manesh R. Patel,Leslee J. Shaw,Raymond F. Stainback +32 more
TL;DR: An appropriate use review of common clinical scenarios where cardiac computed tomography (CCT) is frequently considered found use of CCT angiography for diagnosis and risk assessment in patients with low or intermediate risk or pretest probability for coronary artery disease (CAD) was viewed favorably, whereas testing in high-risk patients, routine repeat testing, and general screening in certain clinical scenarios were viewed less favorably.
Journal ArticleDOI
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology
Sidney C. Smith,Steven N. Blair,Robert O. Bonow,Lawrence M. Brass,Manuel D. Cerqueira,Kathleen Dracup,Valentin Fuster,Antonio M. Gotto,Scott M. Grundy,Nancy Houston Miller,Alice K. Jacobs,Daniel Jones,Ronald M. Krauss,Lori Mosca,Ira S. Ockene,Richard C. Pasternak,Thomas A. Pearson,Marc A. Pfeffer,Rodman D. Starke,Kathryn A. Taubert +19 more
TL;DR: Since the original publication (in 1995) of the AHA consensus statement on secondary prevention, important evidence from clinical trials has emerged that further supports the merits of aggressive risk reduction therapies for patients with atherosclerotic cardiovascular disease.
Journal ArticleDOI
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.
Sidney C. Smith,Steven N. Blair,Robert O. Bonow,Lawrence M. Brass,Manuel D. Cerqueira,Kathleen Dracup,Valentin Fuster,Antonio M. Gotto,Scott M. Grundy,Nancy Houston Miller,Alice K. Jacobs,Daniel W. Jones,Ronald M. Krauss,Lori Mosca,Ira S. Ockene,Richard C. Pasternak,Thomas A. Pearson,Marc A. Pfeffer,Rodman D. Starke,Kathryn A. Taubert +19 more
TL;DR: Since the original publication (in 1995) of the AHA consensus statement on secondary prevention, important evidence from clinical trials has emerged that further supports the merits of aggressive risk reduction therapies for patients with atherosclerotic cardiovascular disease.